EUVIMEDEUVIMED entdecken
MetaanalyseÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 35 Trials including 114 592 Individuals

Nada R Abuknesha iD, James H O'Keefe iD, Frank Qian iD, Nathan L Tintle iD, Yidie Lin iD, Yue Sun, Han-Zhu Qian iD, Paul S Aisen iD, Christine M Albert iD, William J Aronson, Abdul Aziz A Asbeutah, Heike A Bischoff-Ferrari und 27 weitere

Circulation: Arrhythmia and Electrophysiology · 2026-08 · 19 (8)

DOI: 10.1161/circep.125.014785 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Circulation: Arrhythmia and Electrophysiology, 2026-08. Verfasst von Nada R Abuknesha und 38 weiteren Autor:innen. Beteiligte Einrichtung: Fatty Acid Research Institute, Sioux Falls, SD (N.R.A., J.H.O.K., N.L.T., W.S.H.). Hauptthemen laut MEDLINE: Atrial Fibrillation, Eicosapentaenoic Acid, Fatty Acids, Omega-3, Docosahexaenoic Acids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, Intramural NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Recent meta-analyses of randomized controlled trials have raised concerns that treatment with omega-3 fatty acids may increase the risk of atrial fibrillation (AF). However, these meta-analyses included at most 8 trials. The aim of this current meta-analysis was to expand the search by including other eligible omega-3 randomized controlled trials with AF incidence data, incorporating both published and unpublished data. METHODS: Eligible studies were randomized controlled trials investigating daily doses of ≥500 mg/d of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA). Additional inclusion criteria included ≥12 months of treatment with EPA/DHA, participants ≥50 years of age, and, where possible, the absence of known AF/atrial flutter at baseline. The primary outcome was the occurrence of new-onset AF. Our primary hypothesis was that risk for AF would simultaneously depend on both omega-3 dose (above or below 1500 mg/d) and background cardiovascular disease risk status, and that their combined impact on AF risk would be synergistic. RESULTS: A total of 35 randomized controlled trials (37 data sets; n=114 592) were included in this meta-analysis. Only studies including patients at high-risk for cardiovascular disease who were treated with high-doses of EPA/DHA (>1500 mg/d) showed a statistically significant increase in AF risk with a pooled odds ratio (OR) of 1.43 (95% CI, 1.14–1.79) and an absolute risk difference of 0.8% (0.40%–1.1%). None of the other 3 groups showed statistically significant levels of AF risk (odds ratios, 1.07 [high risk–low dose], 1.06 [low risk–low dose], and 1.03 [low risk–high dose]). CONCLUSIONS: This meta-analysis suggests that high-dose EPA/DHA treatment is associated with an increased risk of AF in patients at high cardiovascular disease risk, whereas low-dose EPA/DHA does not appear to increase AF risk, even in high-risk populations. Further prospective studies are needed to evaluate any potential increased risk of higher doses balanced against potential benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationEicosapentaenoic AcidFatty Acids, Omega-3Docosahexaenoic AcidsHumansRandomized Controlled Trials as TopicRisk FactorsTreatment OutcomeRisk AssessmentIncidenceMiddle Aged

Stichwörter der Autor:innen

atrial fibrillationatrial flutterdocosahexaenoic acidseicosapentaenoic acidfatty acids, omega-3

Substanzen

Eicosapentaenoic AcidFatty Acids, Omega-3Docosahexaenoic Acids

Autor:innen und Institutionen

  • Fatty Acid Research Institute, Sioux Falls, SD (N.R.A., J.H.O.K., N.L.T., W.S.H.).
  • Saint Luke's Mid America Heart Institute & University of Missouri-Kansas City (J.H.O.K.).
  • Section of Cardiovascular Medicine, Boston Medical Center & Boston University Chobanian & Avedisian School of Medicine, MA (F.Q.).
  • Department of Epidemiology & Health Statistics, West China School of Public Health & West China Fourth Hospital, Sichuan University, Chengdu (Y.L., Y.S.).
  • GlaxoSmithKline, Rockville, MD (H.-Z.Q.).
  • Alzheimer's Therapeutic Research Institute, Keck School of Medicine, University of Southern California, San Diego (P.S.A.).

ORCID-Profile: Nada R Abuknesha, James H O'Keefe, Frank Qian, Nathan L Tintle, Yidie Lin, Han-Zhu Qian, Paul S Aisen, Christine M Albert, Matthew J Budoff, Nicholas R Burns, Cecilia A Cardenas, Cynthia M Carlsson, Emily Y Chew, Amana Liddell, Mark A Hull, Tsuo-Hung Lan, Pan-Yen Lin, Anne-Marie Minihane, Joseph F Quinn, Thomas A B Sanders, Andrew Scholey, Kirsty Sprange, Kuan-Pin Su, Christopher H van Dyck, Carol A Van Hulle, David Vauzour, Claire Weber, Francine K Welty, Gary Wittert, William S Harris

Förderung

  • NHLBI NIH HHS
  • Intramural NIH HHS

Zitieren

APA

Abuknesha, N. R., O'Keefe, J. H., Qian, F., Tintle, N. L., Lin, Y., Sun, Y., Qian, H. Z., Aisen, P. S., Albert, C. M., Aronson, W. J., Asbeutah, A. A. A., Bischoff-Ferrari, H. A., Budoff, M. J., Burns, N. R., Cardenas, C. A., Carlsson, C. M., Chew, E. Y., Cohen, N. J., Fezeu, L. K., …, & Harris, W. S. (2026). Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 35 Trials including 114 592 Individuals. Circulation: Arrhythmia and Electrophysiology, 19(8). https://doi.org/10.1161/circep.125.014785

Vancouver

Abuknesha NR, O'Keefe JH, Qian F, Tintle NL, Lin Y, Sun Y, et al. Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 35 Trials including 114 592 Individuals. Circulation: Arrhythmia and Electrophysiology. 2026;19(8). doi:10.1161/circep.125.014785

BibTeX
@article{Abuknesha2026,
  author = {Abuknesha, Nada R and O'Keefe, James H and Qian, Frank and Tintle, Nathan L and Lin, Yidie and Sun, Yue and Qian, Han-Zhu and Aisen, Paul S and Albert, Christine M and Aronson, William J and Asbeutah, Abdul Aziz A and Bischoff-Ferrari, Heike A and Budoff, Matthew J and Burns, Nicholas R and Cardenas, Cecilia A and Carlsson, Cynthia M and Chew, Emily Y and Cohen, Neal J and Fezeu, Léopold K and Liddell, Amana and Galan, Pilar and Hull, Mark A and Lan, Tsuo-Hung and Lin, Pan-Yen and Mengelberg, Alexia and Minihane, Anne-Marie and Quinn, Joseph F and Sanders, Thomas A B and Scholey, Andrew and Schoenfeld, David A and Sprange, Kirsty and Su, Kuan-Pin and van Dyck, Christopher H and Van Hulle, Carol A and Vauzour, David and Weber, Claire and Welty, Francine K and Wittert, Gary and Harris, William S},
  title = {Effects of Omega-3 Fatty Acid Treatment on Risk for Atrial Fibrillation: An Updated Meta-Analysis of 35 Trials including 114 592 Individuals},
  journal = {Circulation: Arrhythmia and Electrophysiology},
  year = {2026},
  volume = {19},
  number = {8},
  doi = {10.1161/circep.125.014785}
}
Kostenlos starten →